cagrilintide vs semaglutide Cagrilintide–semaglutide (CagriSema) versus or in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, phase 3 study Novo Nordisk to initiate study

If you lose HSA eligibility, you still own the account and can use the funds for qualified expenses, but you must stop contributing until you regain eligibility

Woman in clinical trial for new weight loss drug lost 60 pounds in less than a year An experimental drug from Eli Lilly called retatrutide has shown promising weight loss results in a mid-stage clinical trial, with participants losing an average of 24% of their body weight, equivalent to about 58 pounds

Patients with certain FTO variants show slower initial response but better long-term sustainability, while MC4R variants correlate with earlier adaptation

At Slimming Solutions Med Spa, were preparing to offer retatrutide when it becomes available

Deductibles, copays, and coinsurance vary by plan